Status: current, Defined. Date: 30-Nov 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4760571000168116 | Abevmy (bevacizumab 100 mg / 4 mL) injection, 4 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4760581000168118 | Abevmy 100 mg/4 mL injection, 4 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Abevmy 100 mg/4 mL injection, 4 mL vial | Is a | Abevmy | true | Inferred relationship | Some | ||
| Abevmy 100 mg/4 mL injection, 4 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Abevmy 100 mg/4 mL injection, 4 mL vial | Is a | bevacizumab 100 mg / 4 mL injection, 4 mL vial (medicinal product unit of use) | true | Inferred relationship | Some | ||
| Abevmy 100 mg/4 mL injection, 4 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Abevmy 100 mg/4 mL injection, 4 mL vial | has Australian BoSS | bevacizumab | true | Inferred relationship | Some | 448536968 | |
| Abevmy 100 mg/4 mL injection, 4 mL vial | has intended active ingredient | bevacizumab | true | Inferred relationship | Some | 448536968 | |
| Abevmy 100 mg/4 mL injection, 4 mL vial | has unit of use | vial | true | Inferred relationship | Some | 289861210 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Abevmy 100 mg/4 mL injection, 4 mL vial | has TPUU | True | Abevmy 100 mg/4 mL injection, 4 mL vial | Inferred relationship | Some | 1587341659 |
| Abevmy 100 mg/4 mL injection, 4 mL vial | has TPUU | True | Abevmy 100 mg/4 mL injection, 4 mL vial | Inferred relationship | Some | 1500684956 |
Reference Sets
Trade product unit of use reference set
FHIR